Medicare Enrolled
Dr. Mathew Alias, D.O.
Neurology · Morristown, NJ
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Alias from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Alias?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Alias
Dr. Mathew Alias is a neurology specialist in Morristown, NJ, with 18 years of NPI registration. Based on federal Medicare data, Dr. Alias performed 6,808 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Alias received a total of $13,310 from 95 pharmaceutical and/or device companies across 934 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Alias is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years of NPI registration
▲ Top 11% volume in NJ
$13,310 industry payments
Medicare Practice Summary — 2023
Medicare Utilization ↗6,808
Medicare services
Top 11% in NJ for neurology
Not available
Unique patients (not deduplicated)
$22
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
5,710 | $5 | $7 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
449 | $102 | $145 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
223 | $133 | $190 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
127 | $66 | $103 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
89 | $147 | $193 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
56 | $111 | $142 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
44 | $129 | $207 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
41 | $68 | $86 |
| New patient office visit, complex (60-74 min) | 29 | $190 | $253 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
27 | $102 | $130 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
13 | $163 | $255 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
Industry Payment Transparency
Open Payments through 2024 ↗$13,310
Total received (2018-2024)
Avg $1,901/year across 7 years
Top 21% in NJ for neurology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
95
Companies
934
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$1,758
2023
$2,117
2022
$2,065
2021
$1,979
2020
$1,483
2019
$2,171
2018
$1,738
Payments by company (2024)
ABBVIE INC.
$384
Celgene Corporation
$158
Lundbeck LLC
$120
TG Therapeutics, Inc.
$119
PFIZER INC.
$106
Novartis Pharmaceuticals Corporation
$102
Neurocrine Biosciences, Inc.
$96
Teva Pharmaceuticals USA, Inc.
$90
UCB, Inc.
$70
Biogen, Inc.
$69
Lilly USA, LLC
$67
CSL Behring
$61
AstraZeneca Pharmaceuticals LP
$48
Alexion Pharmaceuticals, Inc.
$36
Eisai Inc.
$35
EMD Serono, Inc.
$32
Amneal Pharmaceuticals LLC
$31
GE HEALTHCARE
$29
Aucta Pharmaceuticals, Inc.
$23
ARGENX US, INC.
$19
Vanda Pharmaceuticals Inc.
$18
Genentech USA, Inc.
$17
SK Life Science, Inc.
$15
Otsuka America Pharmaceutical, Inc.
$13
Top 3 companies account for 37.6% of 2024 payments
All-time payments by company (2018-2024) ›
Novartis Pharmaceuticals Corporation
$1,173
ABBVIE INC.
$813
Biogen, Inc.
$793
Teva Pharmaceuticals USA, Inc.
$748
UCB, Inc.
$563
AbbVie Inc.
$546
Allergan, Inc.
$478
Sunovion Pharmaceuticals Inc.
$451
Celgene Corporation
$426
Lundbeck LLC
$419
PFIZER INC.
$402
Supernus Pharmaceuticals, Inc.
$394
Amgen Inc.
$388
Medtronic USA, Inc.
$372
Alexion Pharmaceuticals, Inc.
$295
Neurocrine Biosciences, Inc.
$287
Allergan Inc.
$283
Lilly USA, LLC
$278
CSL Behring
$219
EMD Serono, Inc.
$208
Eisai Inc.
$205
Genentech USA, Inc.
$177
Acorda Therapeutics, Inc
$142
SK Life Science, Inc.
$138
GE HEALTHCARE
$125
TG Therapeutics, Inc.
$119
Abbott Laboratories
$117
Janssen Pharmaceuticals, Inc
$112
Amneal Pharmaceuticals LLC
$101
Validus Pharmaceuticals LLC
$100
Adamas Pharmaceuticals, Inc.
$97
AstraZeneca Pharmaceuticals LP
$95
GENZYME CORPORATION
$92
Nevro Corp.
$88
ARBOR PHARMACEUTICALS, INC.
$86
UPSHER-SMITH LABORATORIES LLC
$83
W. L. Gore & Associates, Inc.
$81
TG THERAPEUTICS, INC.
$78
Grifols USA, LLC
$70
Scilex Pharmaceuticals Inc.
$64
Avion Pharmaceuticals
$62
Takeda Pharmaceuticals U.S.A., Inc.
$61
Mitsubishi Tanabe Pharma America, Inc.
$60
LivaNova USA, Inc.
$57
CATALYST PHARMACEUTICALS, INC.
$57
JAZZ PHARMACEUTICALS INC.
$56
BOSTON SCIENTIFIC CORPORATION
$48
Boston Scientific Corporation
$47
Bausch Health US, LLC
$46
Currax Pharmaceuticals LLC
$43
Aprecia Pharmaceuticals, LLC
$43
Arbor Pharmaceuticals, Inc.
$43
Kyowa Kirin, Inc.
$43
Impax Laboratories, Inc.
$42
Biohaven Pharmaceutical Holding Company Ltd.
$41
Mallinckrodt LLC
$41
ACADIA Pharmaceuticals Inc
$40
Vanda Pharmaceuticals Inc.
$33
Life Molecular Imaging Ltd
$33
Almatica Pharma LLC
$30
Otsuka America Pharmaceutical, Inc.
$30
Avanir Pharmaceuticals, Inc.
$29
Bayer HealthCare Pharmaceuticals Inc.
$29
BANNER LIFE SCIENCES, LLC
$28
Greenwich Biosciences, Inc.
$28
EISAI INC.
$27
Neurelis, Inc.
$27
Alnylam Pharmaceuticals Inc.
$27
ANI Pharmaceuticals, Inc.
$27
GE HealthCare
$27
Assertio Therapeutics, Inc.
$26
Merz Pharmaceuticals, LLC
$25
Aucta Pharmaceuticals, Inc.
$23
ARGENX US, INC.
$19
Exeltis, USA Inc.
$18
Axsome Therapeutics, Inc.
$17
E.R. Squibb & Sons, L.L.C.
$16
Merz North America, Inc.
$16
IMPEL PHARMACEUTICALS INC.
$16
Piramal Imaging Limited
$16
Banner Life Sciences, LLC
$16
Octapharma USA, Inc.
$15
Akcea Therapeutics, Inc.
$15
Mallinckrodt Enterprises LLC
$15
Virtus Pharmaceuticals LLC
$14
Adlon Therapeutics L.P.
$14
ASSERTIO THERAPEUTICS, Inc.
$14
Biohaven Pharmaceuticals, Inc.
$14
MITSUBISHI TANABE PHARMA AMERICA, INC.
$14
Jazz Pharmaceuticals Inc.
$14
US WorldMeds, LLC
$13
AQUESTIVE THERAPEUTICS, INC.
$13
Alfasigma USA, Inc.
$13
Mylan Specialty L.P.
$12
Sobi, Inc
$12
Top 3 companies account for 20.9% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ACTIVA · ADHANSIA XR · ADUHELM · AFINITOR · AIMOVIG · AJOVY · AMPYRA · AMYVID · ANDEXXA · APTIOM · AUBAGIO · AUSTEDO · AVONEX · Aimovig · Austedo XR · BAFIERTAM · BOTOX · BOTOX THERAPEUTIC · BRILINTA · BRIUMVI · Betaseron · Briviact · CAMBIA · CARDIOFORM Septal Occluder · COMIRNATY · CREXONT · Cambia · Corlanor · DUOPA · Dhivy · ELIQUIS · EMGALITY · Enspryng · Epidiolex · Equetro · FIRDAPSE · Fycompa · GAMMAGARD · GENERAL - DBS · GILENYA · GOCOVRI · GORE CARDIOFORM Septal Occluder · GRALISE · Gamunex-C · General - DBS · Glatiramer Acetate · HETLIOZ · Hizentra · Horizant · INBRIJA · INFINITY · INGREZZA · KESIMPTA · KYNMOBI · LEMTRADA · LEQEMBI · LEVORPHANOL TARTRATE · LYRICA · Leqembi · MAVENCLAD · MAYZENT · MIGRANAL · Mavenclad · Motpoly XR · NAMZARIC · NEURACEQ · NORTHERA · NOURIANZ · NUEDEXTA · NUPLAZID · NURTEC ODT · Nayzilam · Neupro · Neuromodulation Dspsbls and Accs · Nourianz · OCREVUS · ONGENTYS · ONPATTRO · ONZETRA XSAIL · OXTELLAR XR · Ocrevus · Omnia · Ongentys · PANZYGA · PAXLOVID · PLEGRIDY · PONVORY · PURIFIED CORTROPHIN GEL · Ponvory · QULIPTA · RADICAVA · REXULTI · RYTARY · Radicava · SOLIRIS · SPINRAZA · SUNOSI · SYMPAZAN · Senza · Spritam · Sunosi · TECFIDERA · TEGSEDI · TOSYMRA · TROKENDI XR · TYSABRI · Trudhesa · UBRELVY · ULTOMIRIS · VALTOCO · VNS Therapy · VRAYLAR · VUMERITY · VYEPTI · VYVGART HYTRULO · Vimpat · WAINUA · XEOMIN · XYREM · XYWAV · Xadago · Xeomin · ZEMBRACE SYMTOUCH · ZEPOSIA · ZTLido
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Neurologists in nearby ZIP areas
294
County median income
$134,929
Nearest hospital to ZIP centroid (approximate)
GREYSTONE PARK PSYCHIATRIC HOSPITAL
4.7 mi
4.7 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Alias is a mixed practice specialist, with above-average Medicare volume (top 11% in NJ), with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Alias experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Alias performed 5,710 botox injection, per unit services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Alias receive payments from pharmaceutical companies?
Yes. Dr. Alias received a total of $13,310 from 95 companies across 934 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Alias's costs compare to other neurologists in Morristown?
Dr. Alias's average Medicare payment per service is $22. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Alias) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Neurology
Common procedures, typical costs, and what industry payments mean in neurology.
Same specialty & city
Neurologists in Morristown
Browse neurologists in Morristown ranked by procedure volume and transparency data.
Highest volume
Top Neurologists in NJ
Neurologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Neurologists in NJ
Which NJ neurologists receive the most from drug and device companies.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
By company
Biogen, Inc. Payments to Doctors
See all physicians who received payments from Biogen, Inc.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology